Top Wall Street Analyst Upgrades and Positive Views

Investors and traders are always on the lookout for fresh research ideas from Wall St. that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls to find great ideas from value stocks to growth stocks to dividend stocks. We are breaking out the positive analyst calls as far as stocks to buy and positive research calls today. These are some of this Wednesday’s top analyst upgrades, initiations and positive analyst research calls seen from Wall St. today.

CVS Caremark Corp. (NYSE: CVS) was reiterated Buy at Argus, but the firm raised the price target to $64 from $58.

DirecTV (NASDAQ: DTV) was started as Buy at Stifel Nicolaus.

Gilead Sciences Inc. (NASDAQ: GILD) was reiterated as Outperform and its target price was raised to $59 from $50 at Oppenheimer.

Intel Corp. (NASDAQ: INTC) reiterated Outperform with $28 price target at Credit Suisse as the firm said that it is not sure what the bears are still playing for, and that Intel’s business model continues to be significantly more resilient than feared.

Lululemon Athletica Inc. (NASDAQ: LULU) was initiated as Overweight along with a $85 price target at Barclays, based on recent weakness and the company getting its quality control issues back in line.

Qihoo 360 Technology Co. Ltd. (NYSE: QIHU) was initiated as Overweight along with a $38 price target at Barclays.

Yahoo! Inc. (NASDAQ: YHOO) was raised to Buy with $28 target price at BofA/Merrill Lynch. The call is on its Alibaba holdings rather than on core operations. Stifel Nicolaus reiterated its Buy rating and raised its price target to $27 from $25. Yahoo! was also reiterated as Outperform with a $27 target price at Oppenheimer. Shares are down more than 2% around $23.30 so far after earnings.

See also: Analysts Defend Battered Gold-Mining Stocks